﻿<!--Use of the Calais Web Service is governed by the Terms of Service located at http://www.opencalais.com. By using this service or the results of the service you agree to these terms of service.-->
<!--Relations: CompanyEarningsAnnouncement, Quotation, PersonProfessional

Region: Eastern Europe
Product: Topamax
Organization: Food and Drug Administration, Consumer Healthcare Products Association
IndustryTerm: software, software piracy declines, epilepsy treatment, Drug developer
Country: United States, Brazil, China
Company: Ortho McNeil Pharmaceuticals, Mylan Laboratories Inc., Adobe, Adobe Systems
URL: http://reports.huginonline.com/915745/122470.pdf, http://www.macromedia.com/go/buymx2004, ftp://ftp.demon.co.uk/pub/mirrors/garbo
Currency: USD
Person: Shantanu Narayen
Technology: Acrobat-->
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:c="http://s.opencalais.com/1/pred/">
  <rdf:Description c:allowDistribution="true" c:allowSearch="true" c:externalID="MyExternId" c:id="http://id.opencalais.com/jLpnVdhyfao2P2kcQIvVog" rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/DocInfo"/>
    <c:document>
      <![CDATA[<Document><Title>1214127640077-746EE973-700055</Title><Date>2008-06-22</Date><Body>Overseas sales boost Adobe profit   
  
US software company Adobe Systems has reported a 41% jump in second-quarter profit thanks to robust demand from international markets.  
 
However, the maker of Photoshop, Flash and Acrobat issued a revenue outlook that disappointed some investors, sending its shares down 2.5%.  
 
Adobe's net income in the three months to May 30 was $214.9m (109m), up from $152m in the same quarter a year ago.  
 
The company added that sales were flat in the US.  
 
Demand 'remains strong'  
 
Adobe said it expected revenue in the third quarter to be in a range of $855m to $885m.  
 
The firm's chief executive Shantanu Narayen said that while Adobe had so far weathered the US economic slowdown, this could change.  
 
"I'm not an economist. All I can do is reflect on what I have seen so far," he said. "Demand for our products remains strong. (But) we are not immune to a recession."  
 
However, Mr Narayen added he expected international sales to continue to be strong, with Eastern Europe, Brazil and China offering opportunities for growth as software piracy declines.  
 
Adobe shares fell $1.05 to $41.80 in after-hours trading. 
 
Laughlin has been active for many years in the Consumer Healthcare Products Association. 
 
Drug developer Mylan Laboratories Inc. said Monday the Food and Drug Administration approved its generic version of Ortho McNeil Pharmaceuticals' epilepsy treatment Topamax. 
 
http://www.macromedia.com/go/buymx2004/ 
 
http://reports.huginonline.com/915745/122470.pdf 
 
ftp://ftp.demon.co.uk/pub/mirrors/garbo/</Body></Document>]]>
    </c:document>
    <c:externalMetadata/>
    <c:submitter>MySubmitterId</c:submitter>
  </rdf:Description>
  <rdf:Description c:contentType="text/txt" c:emVer="UnifiedIM-DJ" c:langIdVer="DefaultLangId" c:language="English" c:processingVer="CalaisJob01" c:submissionDate="2008-06-22 05:40:40.077" rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/meta">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/DocInfoMeta"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:submitterCode>f80bba29-9c5e-01d8-73dc-eb6a93c6931c</c:submitterCode>
    <c:signature>digestalg-1|DHwNuAjsvY5iRrG5j0+wN2Vpqq0=|RlQE3xgju3GLN127quUjcBu5/HB35w5e8kuDq7/plJhvTOIJdVW6Mw==</c:signature>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/lid/DefaultLangId">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/lid/DefaultLangId"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:lang rdf:resource="http://d.opencalais.com/lid/DefaultLangId/English"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/99f21627-35fc-3e68-bf41-0c2f2015011a">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/IndustryTerm"/>
    <c:name>software piracy declines</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/1">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/99f21627-35fc-3e68-bf41-0c2f2015011a"/>
    <!--IndustryTerm: software piracy declines-->
    <c:detection>
      [and China offering opportunities for growth as ]software piracy declines[.

      Adobe shares fell $1.05 to $41.80 in]
    </c:detection>
    <c:offset>1165</c:offset>
    <c:length>24</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/d1059b0f-6632-35a1-bf29-ef4f5ca46d2e">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Technology"/>
    <c:name>Acrobat</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/2">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/d1059b0f-6632-35a1-bf29-ef4f5ca46d2e"/>
    <!--Technology: Acrobat-->
    <c:detection>
      [

      However, the maker of Photoshop, Flash and ]Acrobat[ issued a revenue outlook that disappointed some]
    </c:detection>
    <c:offset>305</c:offset>
    <c:length>7</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/comphash-1/3a64ad4a-d358-3890-9214-0992d8ca251d">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Company"/>
    <c:name>Mylan Laboratories Inc.</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/3">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/3a64ad4a-d358-3890-9214-0992d8ca251d"/>
    <!--Company: Mylan Laboratories Inc.-->
    <c:detection>
      [Products Association.

      Drug developer ]Mylan Laboratories Inc.[ said Monday the Food and Drug Administration]
    </c:detection>
    <c:offset>1363</c:offset>
    <c:length>23</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/8fdc5526-3c7b-34ef-ad60-a7ca8f091ec2">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/IndustryTerm"/>
    <c:name>Drug developer</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/4">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/8fdc5526-3c7b-34ef-ad60-a7ca8f091ec2"/>
    <!--IndustryTerm: Drug developer-->
    <c:detection>
      [ the Consumer Healthcare Products Association.

      ]Drug developer[ Mylan Laboratories Inc. said Monday the Food and]
    </c:detection>
    <c:offset>1348</c:offset>
    <c:length>14</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/a587a72c-d83d-3466-9a9a-ae42e86619b2">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/r/CompanyEarningsAnnouncement"/>
    <!--Adobe-->
    <c:company rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
    <c:quarter>Q</c:quarter>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/5">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/a587a72c-d83d-3466-9a9a-ae42e86619b2"/>
    <!--CompanyEarningsAnnouncement: company: Adobe; quarter: Q; -->
    <c:detection>
      [investors, sending its shares down 2.5%.

      ]Adobe's net income in the three months to May 30 was $214.9m[ (109m), up from $152m in the same quarter a year]
    </c:detection>
    <c:offset>406</c:offset>
    <c:length>60</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Currency"/>
    <c:name>USD</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/6">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2"/>
    <!--Currency: USD-->
    <c:detection>[net income in the three months to May 30 was ]$214.9m[ (109m), up from $152m in the same quarter a year]</c:detection>
    <c:offset>459</c:offset>
    <c:length>7</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/7">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2"/>
    <!--Currency: USD-->
    <c:detection>
      [months to May 30 was $214.9m (109m), up from ]$152m[ in the same quarter a year ago.

      The company]
    </c:detection>
    <c:offset>483</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/8">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2"/>
    <!--Currency: USD-->
    <c:detection>
      [ revenue in the third quarter to be in a range of ]$855m[ to $885m.

      The firm's chief executive]
    </c:detection>
    <c:offset>679</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/9">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2"/>
    <!--Currency: USD-->
    <c:detection>
      [the third quarter to be in a range of $855m to ]$885m[.

      The firm's chief executive Shantanu Narayen]
    </c:detection>
    <c:offset>688</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/10">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2"/>
    <!--Currency: USD-->
    <c:detection>
      [software piracy declines.

      Adobe shares fell ]$1.05[ to $41.80 in after-hours trading.

      Laughlin]
    </c:detection>
    <c:offset>1213</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/11">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/736a403d-157b-3e80-86a7-acc404607cb2"/>
    <!--Currency: USD-->
    <c:detection>
      [piracy declines.

      Adobe shares fell $1.05 to ]$41.80[ in after-hours trading.

      Laughlin has been]
    </c:detection>
    <c:offset>1222</c:offset>
    <c:length>6</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/f86c0b0f-2200-32a1-968b-5adf2c1a1806">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/r/Quotation"/>
    <!--Shantanu Narayen-->
    <c:person rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <c:quote>while Adobe had so far weathered the US economic slowdown, this could change.</c:quote>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/12">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/f86c0b0f-2200-32a1-968b-5adf2c1a1806"/>
    <!--Quotation: person: Shantanu Narayen; quote: while Adobe had so far weathered the US economic slowdown, this could change.; -->
    <c:detection>
      [quarter to be in a range of $855m to $885m.

      ]The firm's chief executive Shantanu Narayen said that while Adobe had so far weathered the US economic slowdown, this could change.[

      "I'm not an economist. All I can do is]
    </c:detection>
    <c:offset>699</c:offset>
    <c:length>131</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/comphash-1/e8d83719-1c1a-34de-bccc-e673e333ff01">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Company"/>
    <c:name>Adobe Systems</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/13">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/e8d83719-1c1a-34de-bccc-e673e333ff01"/>
    <!--Company: Adobe Systems-->
    <c:detection>
      [boost Adobe profit

      US software company ]Adobe Systems[ has reported a 41% jump in second-quarter profit]
    </c:detection>
    <c:offset>143</c:offset>
    <c:length>13</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/48d394d3-f430-38e5-8e43-6b9cd2f8c886">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Country"/>
    <c:name>United States</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/14">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/48d394d3-f430-38e5-8e43-6b9cd2f8c886"/>
    <!--Country: United States-->
    <c:detection>
      [sales boost Adobe profit

      ]US[ software company Adobe Systems has reported a]
    </c:detection>
    <c:offset>123</c:offset>
    <c:length>2</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/15">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/48d394d3-f430-38e5-8e43-6b9cd2f8c886"/>
    <!--Country: United States-->
    <c:detection>
      [

      The company added that sales were flat in the ]US[.

      Demand 'remains strong'

      Adobe said it]
    </c:detection>
    <c:offset>571</c:offset>
    <c:length>2</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/16">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/48d394d3-f430-38e5-8e43-6b9cd2f8c886"/>
    <!--Country: United States-->
    <c:detection>
      [said that while Adobe had so far weathered the ]US[ economic slowdown, this could change.

      "I'm]
    </c:detection>
    <c:offset>790</c:offset>
    <c:length>2</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/c2759426-70dc-3b30-8e78-bf4373cd3d56">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/IndustryTerm"/>
    <c:name>software</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/17">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/c2759426-70dc-3b30-8e78-bf4373cd3d56"/>
    <!--IndustryTerm: software-->
    <c:detection>
      [sales boost Adobe profit

      US ]software company[ Adobe Systems has reported a 41% jump in]
    </c:detection>
    <c:offset>126</c:offset>
    <c:length>16</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Person"/>
    <c:name>Shantanu Narayen</c:name>
    <c:persontype>economic</c:persontype>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/18">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <!--Person: Shantanu Narayen-->
    <c:detection>
      [$855m to $885m.

      The firm's chief executive ]Shantanu Narayen[ said that while Adobe had so far weathered the]
    </c:detection>
    <c:offset>726</c:offset>
    <c:length>16</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/19">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <!--Person: Shantanu Narayen-->
    <c:detection>[ I can do is reflect on what I have seen so far," ]he[ said. "Demand for our products remains strong.]</c:detection>
    <c:offset>911</c:offset>
    <c:length>2</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/20">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <!--Person: Shantanu Narayen-->
    <c:detection>
      [we are not immune to a recession."

      However, ]Mr Narayen[ added he expected international sales to]
    </c:detection>
    <c:offset>1015</c:offset>
    <c:length>10</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/21">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <!--Person: Shantanu Narayen-->
    <c:detection>
      [to a recession."

      However, Mr Narayen added ]he[ expected international sales to continue to be]
    </c:detection>
    <c:offset>1032</c:offset>
    <c:length>2</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/ed27d47d-7617-3057-865e-ed86642966ee">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/URL"/>
    <c:name>ftp://ftp.demon.co.uk/pub/mirrors/garbo</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/22">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/ed27d47d-7617-3057-865e-ed86642966ee"/>
    <!--URL: ftp://ftp.demon.co.uk/pub/mirrors/garbo-->
    <c:detection>
      [tp://reports.huginonline.com/915745/122470.pdf

      ]ftp://ftp.demon.co.uk/pub/mirrors/garbo[/&lt;/Body&gt;&lt;/Document&gt;]
    </c:detection>
    <c:offset>1620</c:offset>
    <c:length>39</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/4a8b8290-e002-3369-9de3-4e58210d0cd9">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Country"/>
    <c:name>Brazil</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/23">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/4a8b8290-e002-3369-9de3-4e58210d0cd9"/>
    <!--Country: Brazil-->
    <c:detection>[to continue to be strong, with Eastern Europe, ]Brazil[ and China offering opportunities for growth as]</c:detection>
    <c:offset>1111</c:offset>
    <c:length>6</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/32fc0423-9d4e-3beb-abe3-6885034f2824">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/IndustryTerm"/>
    <c:name>epilepsy treatment</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/24">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/32fc0423-9d4e-3beb-abe3-6885034f2824"/>
    <!--IndustryTerm: epilepsy treatment-->
    <c:detection>
      [ generic version of Ortho McNeil Pharmaceuticals' ]epilepsy treatment[ Topamax.

      http://www.macromedia.com/go/buymx200]
    </c:detection>
    <c:offset>1494</c:offset>
    <c:length>18</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/9641ed41-ff1b-348a-89ca-d4ed19091172">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Country"/>
    <c:name>China</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/25">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/9641ed41-ff1b-348a-89ca-d4ed19091172"/>
    <!--Country: China-->
    <c:detection>[to be strong, with Eastern Europe, Brazil and ]China[ offering opportunities for growth as software]</c:detection>
    <c:offset>1122</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Company"/>
    <c:name>Adobe</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/26">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
    <!--Company: Adobe-->
    <c:detection>
      [&lt;Date&gt;2008-06-22&lt;/Date&gt;&lt;Body&gt;Overseas sales boost ]Adobe[ profit

      US software company Adobe Systems]
    </c:detection>
    <c:offset>104</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/27">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
    <!--Company: Adobe-->
    <c:detection>
      [investors, sending its shares down 2.5%.

      ]Adobe['s net income in the three months to May 30 was]
    </c:detection>
    <c:offset>406</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/28">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
    <!--Company: Adobe-->
    <c:detection>
      [flat in the US.

      Demand 'remains strong'

      ]Adobe[ said it expected revenue in the third quarter to]
    </c:detection>
    <c:offset>607</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/29">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
    <!--Company: Adobe-->
    <c:detection>[ chief executive Shantanu Narayen said that while ]Adobe[ had so far weathered the US economic slowdown,]</c:detection>
    <c:offset>759</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/30">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
    <!--Company: Adobe-->
    <c:detection>
      [for growth as software piracy declines.

      ]Adobe[ shares fell $1.05 to $41.80 in after-hours]
    </c:detection>
    <c:offset>1195</c:offset>
    <c:length>5</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/19bfa501-8287-379a-ac74-2078f2c75cb3">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/r/Quotation"/>
    <!--Shantanu Narayen-->
    <c:person rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <c:quote>he expected international sales to continue to be strong, with Eastern Europe, Brazil and China offering opportunities for growth as software piracy declines</c:quote>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/31">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/19bfa501-8287-379a-ac74-2078f2c75cb3"/>
    <!--Quotation: person: Shantanu Narayen; quote: he expected international sales to continue to be strong, with Eastern Europe, Brazil and China offering opportunities for growth as software piracy declines; -->
    <c:detection>
      [(But) we are not immune to a recession."

      ]However, Mr Narayen added he expected international sales to continue to be strong, with Eastern Europe, Brazil and China offering opportunities for growth as software piracy declines.[

      Adobe shares fell $1.05 to $41.80 in]
    </c:detection>
    <c:offset>1006</c:offset>
    <c:length>184</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/a05e121a-7f7f-319b-9142-a14b054b1189">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Product"/>
    <c:name>Topamax</c:name>
    <c:producttype>drug</c:producttype>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/32">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/a05e121a-7f7f-319b-9142-a14b054b1189"/>
    <!--Product: Topamax-->
    <c:detection>
      [ Ortho McNeil Pharmaceuticals' epilepsy treatment ]Topamax[.

      http://www.macromedia.com/go/buymx2004/
      ]
    </c:detection>
    <c:offset>1513</c:offset>
    <c:length>7</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/3be1568f-a9d7-308f-9726-daff5f704c74">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/r/PersonProfessional"/>
    <!--Shantanu Narayen-->
    <c:person rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <c:position>chief executive </c:position>
    <!--Adobe-->
    <c:company rdf:resource="http://d.opencalais.com/comphash-1/42e569c8-0135-3ded-afcb-47a33cd02461"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/33">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/3be1568f-a9d7-308f-9726-daff5f704c74"/>
    <!--PersonProfessional: person: Shantanu Narayen; position: chief executive ; company: Adobe; -->
    <c:detection>
      [quarter to be in a range of $855m to $885m.

      ]The firm's chief executive Shantanu Narayen[ said that while Adobe had so far weathered the]
    </c:detection>
    <c:offset>699</c:offset>
    <c:length>43</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/5f0e2d04-8a2a-3dbe-999e-fa61862d54e7">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Region"/>
    <c:name>Eastern Europe</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/34">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/5f0e2d04-8a2a-3dbe-999e-fa61862d54e7"/>
    <!--Region: Eastern Europe-->
    <c:detection>[sales to continue to be strong, with ]Eastern Europe[, Brazil and China offering opportunities for]</c:detection>
    <c:offset>1095</c:offset>
    <c:length>14</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/45f1b4b2-cd54-371d-a18a-011b99619768">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/URL"/>
    <c:name>http://www.macromedia.com/go/buymx2004</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/35">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/45f1b4b2-cd54-371d-a18a-011b99619768"/>
    <!--URL: http://www.macromedia.com/go/buymx2004-->
    <c:detection>
      [Pharmaceuticals' epilepsy treatment Topamax.

      ]http://www.macromedia.com/go/buymx2004[/

      http://reports.huginonline.com/915745/122470.]
    </c:detection>
    <c:offset>1525</c:offset>
    <c:length>38</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/979088dd-adeb-3092-b105-1b06991fc211">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Organization"/>
    <c:name>Food and Drug Administration</c:name>
    <c:organizationtype>governmental civilian</c:organizationtype>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/36">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/979088dd-adeb-3092-b105-1b06991fc211"/>
    <!--Organization: Food and Drug Administration-->
    <c:detection>[Mylan Laboratories Inc. said Monday the ]Food and Drug Administration[ approved its generic version of Ortho McNeil]</c:detection>
    <c:offset>1403</c:offset>
    <c:length>28</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/1823d455-e84d-33b9-900b-e30112c85397">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Organization"/>
    <c:name>Consumer Healthcare Products Association</c:name>
    <c:organizationtype>N/A</c:organizationtype>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/37">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/1823d455-e84d-33b9-900b-e30112c85397"/>
    <!--Organization: Consumer Healthcare Products Association-->
    <c:detection>
      [
      Laughlin has been active for many years in the ]Consumer Healthcare Products Association[.

      Drug developer Mylan Laboratories Inc. said]
    </c:detection>
    <c:offset>1303</c:offset>
    <c:length>40</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/3d2e8122-8871-3f44-80a8-fbdb62c27628">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/r/Quotation"/>
    <!--Shantanu Narayen-->
    <c:person rdf:resource="http://d.opencalais.com/pershash-1/2fb03b9c-91dd-3378-b2fa-f89cac5293f6"/>
    <c:quote>I'm not an economist.; All I can do is reflect on what I have seen so far; Demand for our products remains strong. (But) we are not immune to a recession.</c:quote>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/38">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/3d2e8122-8871-3f44-80a8-fbdb62c27628"/>
    <!--Quotation: person: Shantanu Narayen; quote: I'm not an economist.; All I can do is reflect on what I have seen so far; Demand for our products remains strong. (But) we are not immune to a recession.; -->
    <c:detection>
      [ the US economic slowdown, this could change.

      ]"I'm not an economist. All I can do is reflect on what I have seen so far," he said. "Demand for our products remains strong. (But) we are not immune to a recession."[

      However, Mr Narayen added he expected]
    </c:detection>
    <c:offset>835</c:offset>
    <c:length>166</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/comphash-1/c61f1bb8-f530-3ea8-9181-84aa0388ed43">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/Company"/>
    <c:name>Ortho McNeil Pharmaceuticals</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/39">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/comphash-1/c61f1bb8-f530-3ea8-9181-84aa0388ed43"/>
    <!--Company: Ortho McNeil Pharmaceuticals-->
    <c:detection>
      [Administration approved its generic version of ]Ortho McNeil Pharmaceuticals[' epilepsy treatment Topamax.
      ]
    </c:detection>
    <c:offset>1464</c:offset>
    <c:length>28</c:length>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/genericHasher-1/a22d64f9-b62f-3416-ab04-666bb73c4169">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/em/e/URL"/>
    <c:name>http://reports.huginonline.com/915745/122470.pdf</c:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f/Instance/40">
    <rdf:type rdf:resource="http://s.opencalais.com/1/type/sys/InstanceInfo"/>
    <c:docId rdf:resource="http://d.opencalais.com/dochash-1/3eb331e8-11b9-3500-8724-7e3c4496ba1f"/>
    <c:subject rdf:resource="http://d.opencalais.com/genericHasher-1/a22d64f9-b62f-3416-ab04-666bb73c4169"/>
    <!--URL: http://reports.huginonline.com/915745/122470.pdf-->
    <c:detection>
      [

      http://www.macromedia.com/go/buymx2004/

      ]http://reports.huginonline.com/915745/122470.pdf[

      ftp://ftp.demon.co.uk/pub/mirrors/garbo/&lt;/Body]
    </c:detection>
    <c:offset>1568</c:offset>
    <c:length>48</c:length>
  </rdf:Description>
</rdf:RDF>